Clinical Trial Update: A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder [Phase 2]

View source ↗

Summary

Phase 2 exploratory trial of DA-8010 in patients with overactive bladder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• DA-8010

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED